Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic
- PMID: 33778894
- PMCID: PMC8083761
- DOI: 10.1093/jnci/djab045
Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic led to a near-total cessation of mammography services in the United States in mid-March 2020. It is unclear if screening and diagnostic mammography volumes have recovered to prepandemic levels and whether use has varied by women's characteristics.
Methods: We collected data on 461 083 screening mammograms and 112 207 diagnostic mammograms conducted during January 2019 through July 2020 at 62 radiology facilities in the Breast Cancer Surveillance Consortium. We compared monthly screening and diagnostic mammography volumes before and during the pandemic stratified by age, race and ethnicity, breast density, and family history of breast cancer.
Results: Screening and diagnostic mammography volumes in April 2020 were 1.1% (95% confidence interval [CI] = 0.5% to 2.4%) and 21.4% (95% CI = 18.7% to 24.4%) of the April 2019 prepandemic volumes, respectively, but by July 2020 had rebounded to 89.7% (95% CI = 79.6% to 101.1%) and 101.6% (95% CI = 93.8% to 110.1%) of the July 2019 prepandemic volumes, respectively. The year-to-date cumulative volume of screening and diagnostic mammograms performed through July 2020 was 66.2% (95% CI = 60.3% to 72.6%) and 79.9% (95% CI = 75.4% to 84.6%), respectively, of year-to-date volume through July 2019. Screening mammography rebound was similar across age groups and by family history of breast cancer. Monthly screening mammography volume in July 2020 for Black, White, Hispanic, and Asian women reached 96.7% (95% CI = 88.1% to 106.1%), 92.9% (95% CI = 82.9% to 104.0%), 72.7% (95% CI = 56.5% to 93.6%), and 51.3% (95% CI = 39.7% to 66.2%) of the July 2019 prepandemic volume, respectively.
Conclusions: Despite a strong overall rebound in mammography volume by July 2020, the rebound lagged among Asian and Hispanic women, and a substantial cumulative deficit in missed mammograms accumulated, which may have important health consequences.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Comment in
-
Screening and Diagnostic Mammography Utilization During the COVID-19 Pandemic: Public Health Implications and Future Research Needs.J Natl Cancer Inst. 2021 Sep 4;113(9):1115-1117. doi: 10.1093/jnci/djab046. J Natl Cancer Inst. 2021. PMID: 33778893 Free PMC article. No abstract available.
Similar articles
-
Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.Cancer. 2021 Jun 15;127(12):2111-2121. doi: 10.1002/cncr.33460. Epub 2021 Feb 26. Cancer. 2021. PMID: 33635541 Free PMC article.
-
Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.JAMA Netw Open. 2021 Mar 1;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. JAMA Netw Open. 2021. PMID: 33764423 Free PMC article.
-
Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.J Med Screen. 2016 Mar;23(1):31-7. doi: 10.1177/0969141315595254. Epub 2015 Aug 11. J Med Screen. 2016. PMID: 26265482
-
The Impact of the COVID-19 Pandemic on Breast Imaging.Radiol Clin North Am. 2021 Jan;59(1):1-11. doi: 10.1016/j.rcl.2020.09.008. Epub 2020 Sep 22. Radiol Clin North Am. 2021. PMID: 33222992 Free PMC article. Review.
-
Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.Prev Med. 2021 Oct;151:106542. doi: 10.1016/j.ypmed.2021.106542. Epub 2021 Jun 30. Prev Med. 2021. PMID: 34217409 Free PMC article. Review.
Cited by
-
Noteworthy impacts of COVID-19 pandemic on cancer screening: A systematic review.Fundam Res. 2024 Feb 8;4(3):484-494. doi: 10.1016/j.fmre.2023.12.016. eCollection 2024 May. Fundam Res. 2024. PMID: 38933198 Free PMC article. Review.
-
Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.Prev Med. 2021 Oct;151:106540. doi: 10.1016/j.ypmed.2021.106540. Epub 2021 Jun 30. Prev Med. 2021. PMID: 34217424 Free PMC article.
-
COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.Breast Cancer Res Treat. 2023 Nov;202(1):105-115. doi: 10.1007/s10549-023-06962-8. Epub 2023 Aug 16. Breast Cancer Res Treat. 2023. PMID: 37584882 Free PMC article.
-
Impact of the COVID-19 Pandemic on Breast Cancer Diagnoses.Radiology. 2022 May;303(2):295-296. doi: 10.1148/radiol.2021212477. Epub 2021 Oct 19. Radiology. 2022. PMID: 34665037 Free PMC article. No abstract available.
-
Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.Breast Cancer Res Treat. 2023 Nov;202(2):335-343. doi: 10.1007/s10549-023-07083-y. Epub 2023 Aug 25. Breast Cancer Res Treat. 2023. PMID: 37624552 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous